Medical oncologist & Hemato oncologist
Full Name - Dr.Venkatesh Mushini
MBBS.,MD.,DM, ECMO,MRCP
Consultant Medical oncologist & Hemato Oncologist
Date of Birth - 11-08-1985 Nationality - Indian
Spouse - Radiation oncologist (MD) Mobile & E-mail - 9908396239, 8897858183
venky.mushinidvk@gmail.com
SKILL HIGHLIGTS
• Honest medical professional
• Compassionate medical care
• Empathetic and courteous
• High ethical standards
• Collaborative
MEDICAL QUALIFICATION/EDUCATION
Duration Description of Qualification Board/University
2002-2008 M.B.B.S Government MedicalCollege,Ananathapur DR.NTR university of Health Sciences. AP
2010-2013 M.D (Doctor in Radiation oncology ) MNJIOO& Regional Cancer centre Osmania Medical College DR.NTR university of Health sciences. AP
2014-2017 D.M (Doctorate in Medical oncology) SVIMS
DR. NTR university of Health scienc,AP
09- 2016 to 11-
2016 Resident Medical oncologist (Special
training) Adayar cancer institute Chenni,india
12-2016 to 02-
2017 Resident Medical oncologist (Special
training) CMC Vellore India
2017 European society of Medical oncology
Board(ECMO) Certified European society of Medical oncology.
2019 MRCP (UK) SCE – MEDICAL ONCOLOGY ROYAL COLLEGE OF PHYSICIANS OF UK
2019 ASSOCIATE PROFESSOR OF
MEDICAL ONCOLOGY REPUTED MEDICAL COLLEGE & HOSPITAL.
WORK EXPERIENCE/APPOINMENTS
2008-2009 Internship
(Resident House Surgeon) Osmania General Hospital,
Hyderabad
2013-2014 Consultant.Radiation
oncologist Sushruta cancer hospital,
karimnagar,Telangana .
2017-Present Chief Consultant Medical oncologist
& Hemato oncologist Surya Global Hospital,Kakinada, Andhra pradesh
PROFESSIONAL MEMBERSHIPS & ASSOCIATIONS
2011 - Association of Radiation Oncologists of India (AROI)
2013 - Indian Medical Association (IMA)
2015 - Indian society of Medical & Pediatric oncology (ISMPO)
2017 - European Society of Medical Oncology (ESMO)
2019 - Association of Immuno oncology society of India (IOSI)
AWARDS and HONOURS
1 Participated as a Key speaker in several Cancer awareness Programmes conducted at community level.
2 Attended Several International and National Conferences as a Delegate and Speaker for last 9 years. ( World cancer congress -2018 ; ASCO -2017 )
3 National level Talk on role of Immunotherapy in Squamous cell ca Lung (Key note 407 study)- Best of ASCO-2018
4 State level Talk on updates in CINV and role of Akynzeo(NEPA) -2018
5 State level Talk on Role of Sub cutaneous Herceptin in Breast cancer at sate level-2018
6 District level Cancer care in India -2019
7 CME on Overview of chemotherapy and advances in Medical oncology 2019
8 The University of Texas MD Anderson Cancer Center online certification Immunotherpay in cancer patients & Role of EGFR TKI’s in Lung cancer
9 John Hopkins online certification - Immunotherapy in adjuvant and metastatic Lung cancer.
10 Duke health online certification - Advanced Breast cancer Management
PUBLICATIONS AND PRESENTATIONS
PRESENTATIONS
? As a Primary author - Venkatesh M *^,
1.A rare case of Non Hodgkin Lymphoma of Nasopharyngeal origin with unusual pattern of relapse ; ISMPO 2015 - Abstract
2.A rare incidence of late recurrence of primary as double malignancy ; ISMPO 2015 - Abstract
3. A rare presentation of carcinoma lung as soft tissue mass ; ISMPO 2015 - Abstract
4. Clinical profile &therapy of Hepatocellular carcinoma in a tertiary care -Hospital in Andhrapradesh from South India
A study of 182 cases - ACOS 2016 ; Oral presentation .
5. Clinical profile and outcomes of acute myeloid leukemia: An institutional experience from South India-HEMATOCON 2016 - Abstract
? As a Second Author
1. Synchronous occurrence of CML and Ca breast – a rare combination- HEMATOCON 2016 - Abstract
2. The different clinical scenarious of Plasmablastic Myeloma:A report of two cases of very rare variant of multiple myeloma-ISMPO 2016 - Abstract
3. Paediatric CML data-An Insitutional experience from south india-APCON2017 - Abstract
PUBLICATIONS
Peer reviewed - Corresponding author
1. Clinical profile and Therapy of Hepatocellular Carcinoma at a Teritary care Institute from south india:A Retrospective study of 182 patients-
IJCER Vol 5no 1,january –june 2017 DOI:http://dx.doi.org/10.21088/ijcer.2321.9815.5117.5
2. A study of COX-2 inhibitor celecoxib and chemoradiation in patients with locally advanced Cervical cancer - Jebmh.com – Co author
J. Evid. Based Med. Healthc., pISSN- 2349-2562, eISSN- 2349-2570/ Vol. 3/Issue 68/Aug. 25, 2016
3. Treatment Response and Locoregional Control in Locally Advanced Oral Cavity Cancers with Concurrent Chemoradiation and Radiation Alone– Co author
Indian Journal of Cancer Education and Research 53 Volume 5 Number 2, July - December 2017
DOI: http://dx.doi.org/10.21088/ijcer.2321.9815.5217.1
4. Comparative Study of Folfox 4 Versus Capeox Chemotherapy Regimens in Adjuvant Therapy and Metastatic Colorectal Cancer
Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019
DOI: http://dx.doi.org/10.21088/ijcer.2321.9815.7219.6
5. Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India.
Indian Journal of Cancer Education and Research Volume 7 Number 2, July - December 2019
DOI: http://dx.doi.org/10.21088/ijcer.2321.9815.7219.7